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The cholinergic human neuroepithelioma cell line SK-N-MCIXC expressed mRNAs for the neuropeptides cholecystokinin (CCK), neuropeptide 
Y, gastrin-releasing peptide (GRP) and enkephalin. The CCK transcript of about 800 nt was present at very high levels and CCK-like peptides 
immunoreactive to a C-terminal CCK octapeptide antiserum were present in the cell line and its medium. This clonal neuronal cell line provides 
a unique model system to identify cis- and trans-acting factors responsible for neuron-specific expression and regulation of the CCK gene. Further- 
more, the pluripotent properties of the undifferentiated cell line may open studies on neuronal differentiation at the level of co-expression of neuro- 
peptides and transmitters. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Cholecystokinin (CCK) is a biologically active pep- 
tide of brain and gut [l-3]. Characteristic is the strict 
tissue specificity of CCK gene expression and the dif- 
ferential processing of the CCK precursor. CCK is one 
of the most abundant neuropeptides. It occurs in nearly 
all brain regions, predominantly as the octapeptide 
CCK-8, and has a variety of central effects. 
The upper intestine is the major site of CCK synthesis 
in the gastrointestinal tract, in which various forms of 
CCK exist, including CCK-8, -22, -33, -39 and -58 [3,4]. 
Furthermore, CCK-like peptides are sometimes produc- 
ed by neoplasms. CCK peptides and mRNA have 
previously been detected in medullary thyroid car- 
cinomas, pancreatic islet cell tumors and in rat cell lines 
derived from these [5-71. Recently, CCK has also been 
found in two cell lines of neuronal origin one of which 
is the neuroepithelioma cell line SK-N-MC [8]. When 
expressed at high levels, neuronal cell lines are poten- 
tially useful models to study brain-specific expression 
and regulation of neuropeptide genes. Here we report 
that the clonal human neuroepithelioma cell line SK-N- 
MCIXC co-expresses at least four neuropeptide genes 
of which the CCK gene at very high levels. 
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2.1. Cell culture 
The human neuroepithelioma cell line SK-N-MCIXC was cultured 
in Eagle’s medium (minimal essential medium (MEM)) supplemented 
with 10% heat-inactivated fetal bovine serum, nonessential amino 
acids (Eagle’s formulation), penicillin (100 IU/ml), and streptomycin 
(100 pg/ml) as described [9]. Cells were harvested by trypsinization 12 
h after replacement of fresh medium at a density of IO6 cells/cm’. For 
determination of the peptide content in the medium, cells were kept 
in medium containing 0.5% fetal calf serum for 16 h. The human 
neuroblastoma cell lines LA-N-l, SMS-MSN, and SMS-KAN were 
grown as described [9]. 
2.2. Northern blot analysis 
Total RNA was prepared from washed cell pellets by homogeniza- 
tion in the presence of guanidine isothiocyanate followed by phenol 
extraction and precipitation as described before [lo]. Alternatively, 
DNA-free cellular RNA preparations were obtained by the method of 
Wilkinson [ 111. Total RNA (20 pg) was glyoxylated, subjected to elec- 
trophoresis in a 1.4% agasore gel and transferred to a nylon filter 
(Hybond-N, Amersham International, Amersham UK). Filters were 
prehybridized in 50% formamide, 6 x SSC, 1% SDS, 1% defatted 
milk powder, 100 @g/ml denatured herring sperm DNA, at 50°C for 
6 h and hybridized to ‘*P-labeled DNA probes, synthesized using ran- 
dom hexamer primers [12], in the same solution at 50°C for 16 h. 
Filters were washed in 1 x SSC, 0.1% SDS at room temperature twice 
for 5 min, 0.1% SDS, 0.1 x SSC at 50°C twice for 15 min and in 0.1 
x SSC, 0.1% SDS 2 mM EDTA at 65°C for 30 min and exposed to 
X-ray film. The CCK probe was a 550 bp AM-AluI fragment of exon 
2 of the human CCK gene [ 131. The pro-enkephalin probe was the rat 
cDNA clone pYSEA [14], the neuropeptide Y probe was a 280 bp 
fragment of exon 2 of the rat gene [15] and the gastrin-releasing pep- 
tide (GRP) probe was a 850 bp human cDNA [16]. 
2.3. Radioimmunoassay 
Washed cell pellets (5 x 10’ cells) were extracted according to 
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Rehfeld and Dockray [ 17,181. Briefly, cells were boiled in water for 
10 min, acidified to 1 M acetic acid, sonicated and centrifuged. The 
supernatant was freeze-dried, dissolved in radioimmunoassay (RIA) 
buffer and centrifuged again. Media were collected, boiled for 10 
min, acidified and prepared for RIA as described above. The RIA 
employed antiserum L48, which is directed against he C-terminus of 
CCK [18], rz51-iodinated CCK-8 as tracer and CCK-8 as standard. 
Therefore, CCK-immunoreactivity is expressed in equivalents 
CCK-8. 
2.4. Southern blot ~n~~ys~ 
DNA was prepared from isolated nuclei of SK-N-MCIXC cells and 
human placenta as described HP]. Twenty iup was completely digested 
with the restriction endonucleases EcoRI and NindIII, subjected to 
electrophoresis in 0.7% agarose and transferred to nylon filters (Zeta 
probe, BioRad, Richman, CA) in 2 M sodium hydroxide for 5 h. 
Prehybridization was performed in 1.5 x SSPE (SSPE is 0.18 M 
sodium chloride, 10 mM sodium phosphate, pH 7.0, and 1 mM ED- 
TG), 1% SDS, 0.5% defatted milk powder and 0.5 mg/ml herring 
sperm DNA. Hybridization was done in the same solution containing 
10% dextran sulfate with the ‘*P-labeled human CCK probe (3 x lo6 
cpm/ml) (see above). Blots were finally washed in 0.1 x SSC, 1% 
SDS at 50°C for 30 mm and exposed to X-ray film overnight. 
3. RESULTS AND DISCUSSION 
The human neuronal cell lines LA-N-l, SMS-MSN, 
SMS-KAN and SK-N-MCIXC were analyzed for ex- 
pression of the CCK gene by Northern blot anaiysis of 
total RNA using a probe containing exon 2 of the 
human CCK gene [ 131. CCK expression was only seen 
in the neuroepithelioma cell line SK-N-MCIXC (Fig. 1). 
The content of the CCK transcript in the SK-N-MCIXC 
cell line was extremely high; it was easily detected after 
30 min exposure of the filter containing 20 Bg total 
cellular RNA (Fig. 1). The CCK transcript had a length 
of approximately 800 nt and comigrated with CCK 
mRNA of human brain cortex (not shown). 
The selectivity of expression was further evaluated by 
hybridization of filters with probes for several other 
neuroendocrine peptides. No signals were obtained with 
human vasopressin, oxytocin and pro-opiomelanocor- 
tin probes. Using probes for pro-enkephalin, GRP and 
neuropeptide Y, pro-enkephalin mRNA (- 1200 nt), 
CRP mRNA (-900 nt) and neuropeptide Y mRNA 
(- 700 nt) were detected in cellular and total RNA of 
SK-N-MCIXC cells (Fig. 1). The signals of these 
mRNAs were weaker than those of CCK mRNA on the 
same filters (Fig. 1). Based on the signal intensities and 
exposure times the ratio of CCK mRNA:GRP 
mRNA:enkephalin mRNA:neuropeptide Y mRNA was 
roughly estimated to be 200:20:2: 1. 
The SK-N-MCIXC cell line contained CCK- 
immunoreactivity as determined by RIA. Serial dilu- 
tions of extracts of SK-N-MCIXC cell pellets showed 
displacement of the tracer parallel to the CCK-8 stand- 
ard. The cellular content of CCK-immunoreactivity ex- 
periments was low (15 + 8 pg CCK-8 equivalents per 
10’ cells), but the media contained 227 + 18 pg CCK-8 
equivalents per 10’ cells, indicating that CCK-like 
material was released at high rate into the medium. 
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Fig. 1. Detection of neuropeptide mRNAs in the human neuroepi- 
thelioma cell line SK-N-MCIXC. Twenty Fg of total RNA was analyz- 
ed on the Northern blot. The same blot hybridized to CCK, GRP, 
neuropeptide Y (NPY) and enkephalin (ENK) probes is shown. In 
lane 1 (CCK mRNA), the exposure time was 25 min, in lane 2 (GRP) 
20 h, in lane 3 (ENK) 72 h and in lane 4 (NPY) 24 h. Lane 4 also shows 
the remaining signal of CCK appearing as the lower band (0). 
Taken together, the findings of an abundant - 800 nt 
CCK transcript and CCK-immunoreactivity in the SK- 
N-MCIXC cell line indicates that this neuroepithelioma 
cell line contains an authentic human CCK mRNA 
and produces CCK-like peptides. The cellular content 
of CCK peptides may be lower than expected from the 
high level of CCK mRNA. It has been shown recently 
that the parent cell line SK-N-MC produces pro-CCK 
and pro-enkephalin in unprocessed form [8,20,21]. 
Similarly, most of the translation product of the CCK 
mRNA in SK-N-MCIXC may be partially unprocessed 
as well and was therefore undetectable to the antiserum 
used. The precise forms of CCK-immunoreactivity and 
the extent of processing of the CCK precursor awaits 
further immunological and biosynthetic characteriza- 
tion. 
The human neuroblastoma cell line SK-N-MCIXC is 
a unique cell line of neuronal origin which expresses the 
human CCK gene at very high level. The CCK gene has 
been localized on chromosome 3 122,231. A normal, in- 
tact chromosome 3 appeared absent during cytological 
examination of the genome of SK-N-MCIXC, while 
minichromosomes occurred [9]. Therefore, DNA of 
this cell line was analyzed on Southern blots. Single 
bands of approximately 8 kb and 4 kb, were detected by 
the CCK exon 2 probe on Southern blots of DNA cut 
with &oRI and HndIII, respectively. The size of 
fragments and the intensity of signals were the same as 
in normal human DNA (not shown). The results show 
that the human CCK gene in SK-N-MCIXC is present 
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as a single copy gene with a normal internal organiza- 
tion. Thus, no major amplification or rearrangement of 
the CCK gene has taken place. No instability of CCK 
expression with subsequent passage of cells was 
observed. 
Neuroepithelioma cells are thought to be stem cells or 
immature intermediates to neuroblasts and epithelial 
cells [24,25]. The SK-N-MCIXC cell line was establish- 
ed after twice cloning the heterogeneous human 
neuroepithelioma cell line SK-N-MC [9]. Both cell lines 
display cholinergic properties, including the presence of 
acetylcholin and acetylcholinesterase [24,26]. The ex- 
pression of the cholinergic phenotype and the co- 
expression of several neuropeptide genes (CCK, GRP, 
pro-enkephalin and neuropeptide Y) suggests that the 
undifferentiated SK-N-MCIXC cell line behaves like a 
pluripotent neuronal cell. Therefore, the SK-N-MCIXC 
cell line is not only useful in analyzing cell specificity 
and regulation of CCK gene expression and the transac- 
ting factors involved, but may also provide a valuable 
model for studies on peptide and transmitter co- 
expression during neuronal differentiation. 
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